Lupin Signs An Agreement with Alvion to market Cardiometabolic Drugs in the SEA region
Lupin Limited announced today that it has signed a licensing deal with Alvion Pharmaceuticals P.C. for the commercialization of medicines for cardiometabolic illnesses in Southeast…
Read More...
Read More...